Tag: Translational Genomics Research Institute
-
Helios Scholars at TGen Celebrates 20 Years of Investment in Arizona’s Future Scientists
For 20 years, Helios Scholars at TGen has demonstrated how early access to research labs, mentorship, and hands-on scientific experience can shape students’ career pathways while strengthening Arizona’s future healthcare and bioscience workforce. By allowing students to train alongside researchers tackling real-world health challenges, the program expands access to STEM careers while cultivating the next…
-
Fashion and Philanthropy Unite to Advance Women’s Cancer Research at Runway for Research 2026
Annual Scottsdale event benefiting TGen returns October 9 with an inspiring morning dedicated to accelerating discoveries for women facing cancer PHOENIX – May 27, 2026 – The Translational Genomics Research Institute (TGen), part of City of Hope, together with Neiman Marcus and Scottsdale Fashion Square, will host the sixth annual Runway for Research on Friday, October 9, from 9 to 11 a.m.…
-
TGen Ambassadors Program Marks 10 Years of Community Impact, Advocacy, and Research Support
For the past decade, the Translational Genomics Research Institute (TGen), part of City of Hope, has built the TGen Ambassadors program into a network of community leaders dedicated to advancing life-changing research through philanthropy, advocacy, and networking. The TGen Ambassadors program, launched in 2016, was created to connect executives, entrepreneurs, physicians, attorneys, and other influential…
-
TGen appoints Nhan L. Tran, Ph.D., to faculty as distinguished professor
His lab will focus on advancing immuno‑oncology and microbiome innovation and research on understanding and interrupting tumor–immune interactions The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the appointment of Nhan L. Tran, Ph.D., to its faculty as Distinguished Professor, Vice President of Cancer Discovery and Translation, Co-director of TGen’s Immunology and Microbiome Division,…
-
New TGen Clinical Test for Multiple Myeloma Consolidates Multiple Analyses and Provides Detailed Information in 3 Days
JAYseq, a powerful new whole genome sequencing assay delivers a comprehensive, 72 hour molecular profile to help oncologists personalize care for patients across the myeloma disease spectrum The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseq™, a clinical whole-genome sequencing (WGS) test specifically for multiple myeloma. Approximately 35,000 new…
